e-learning
resources
Vienna 2012
Sunday, 02.09.2012
Update on neutrophil and macrophage function in COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Lipids in the lung: Respiratory inflammation in COPD
A. Higham, S. Lea, K. Simpson, D. Singh (Stevenage, United Kingdom)
Source:
Annual Congress 2012 - Update on neutrophil and macrophage function in COPD
Session:
Update on neutrophil and macrophage function in COPD
Session type:
Oral Presentation
Number:
385
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Higham, S. Lea, K. Simpson, D. Singh (Stevenage, United Kingdom). Lipids in the lung: Respiratory inflammation in COPD. Eur Respir J 2012; 40: Suppl. 56, 385
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Inflammation biomarkers of lung tissue damage in acute exacerbation of COPD patients
Source: Annual Congress 2013 –Biomarkers, diagnosis and outcome of respiratory infections
Year: 2013
Neural respiratory drive during recovery from exacerbations of COPD
Source: Annual Congress 2013 –Respiratory muscles at rest and during exercise: from physiology to clinical context
Year: 2013
Association of the neutrophil-to-lymphocyte ratio with lung function and exacerbations in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
Insulin resistance, lung function and exacerbation rate in chronic obstructive lung disease
Source: International Congress 2015 – Monitoring airway diseases with lung function tests
Year: 2015
Respiratory rehabilitation in the chronic obstructive lung diseases
Source: Eur Respir J 2006; 28: Suppl. 50, 395s
Year: 2006
Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Investigating COPD in longitudinal studies
Year: 2013
Activin-A expression in COPD exacerbations: Local index of airway inflammation? Preliminary results
Source: International Congress 2014 – Mechanisms of COPD and inhalation injury
Year: 2014
Respiratory rehabilitation in the chronical obstructive lung diseases and asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 321s
Year: 2004
Changes in lung mechanics and gas exchange in patients with pulmonary sarcoidosis (PS)
Source: International Congress 2014 – Innovative technology and techniques in respiratory function
Year: 2014
Respiratory work and its components during exercise in interstitial lung disease, COPD and controls
Source: International Congress 2015 – Respiratory muscles and airways function: from physiology to clinical implications
Year: 2015
Blood eosinophils and outcomes in COPD
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016
Etiological structure from sputum of patients with exacerbation of COPD
Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections
Year: 2014
Survival in IPF acute exacerbations: The non-steroid approach
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis and rarities
Year: 2013
Common airway variants and chronic obstructive pulmonary disease
Source: International Congress 2015 – New observations in respiratory epidemiology
Year: 2015
Lung function and respiratory morbidity in children with bronchopulmonary dysplasia
Source: Annual Congress 2013 –Paediatric respiratory epidemiology: new understandings of lung function, disorders of prematurity and chronic airway diseases
Year: 2013
Local and systemic neutrophilic inflammation in patients with lung cancer and chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013
Comparison of adventitious respiratory sounds between stable COPD and AECOPD
Source: International Congress 2015 – Best abstracts in chronic care
Year: 2015
Lung hyperinflation in COPD and asthma
Source: Annual Congress 2010 - Asthma aspect of diagnosis and criteria for follow-up
Year: 2010
Are normal lung sounds on aucultation associated with FEVI and FVC volume changes in Asthma, Chronic Obstructive Pulmonary Disease (COPD) and Interstitial lung disease (ILD)?
Source: International Congress 2019 – Lung function testing: from experimental investigations to clinical applications
Year: 2019
The EvA-Study: Markers of emphysema versus airway disease in COPD
Source: Annual Congress 2009 - EU Research Programmes: 1.GABRIEL 2.EvA 3.COPACETIC
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept